{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:27:02Z","timestamp":1775197622792,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is a limbic encephalitis that rarely presents as an isolated psychiatric syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 70-year-old patient first presented with behavioral disorder including hyperactivity, euphoria, with disinhibition and accelerated speech associated with severe insomnia and cognitive disorder. A manic episode was diagnosed and he received various psychotropic medications with no improvement. Invesitgations were negative (MRI showed T2 aspecific hyperintensities with no hyperintensities in limbic regions and EEG was normal). He was transferred to a nursing home, with a diagnosis of neurodegenerative condition. Later, he was referred to our unit for further investigations. A cerebral 18F-FDG-PET revealed an association of frontal hypometabolism and temporal and striatum hypermetabolism and CSF analysis revealed slightly increased white blood cell counts. Plasmatic anti-LGI1 antibodies were detected. The patient was treated with intra-venous immunoglobulin (IvIg) but showed no improvement. Second-line treatment (a combination of rituximab and cyclophosmphamide) was then administered for a year, leading to an improvement of neuropsychiatric symptoms and normalization of metabolic impairment on 18F-FDG-PET.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this report, we describe a novel case of a patient withanti-LGI1 encephalitis with a predominant long-term psychiatric presentation. An atypical presentation (such as atypical psychiatric symptoms, neurocognitive disorder, and hyponatremia) should prompt further investigations such as CSF analysis, considering that MRI and EEG may be normal. FDG-PET might be of interest but few data are available in the literature. Early treatment of anti-LGI1 encephalitis is crucial for overall prognosis and may delay the development of dementia in some cases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1168302","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T07:51:49Z","timestamp":1684396309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Federica","family":"Porpiglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangeline","family":"Bliaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Decazes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Guillin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Roth\u00e4rmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"Sonderen","year":"2016","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2018.02.005","article-title":"Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis","volume":"317","author":"Jang","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P6.124","article-title":"Anti-LGI1-associated cognitive impairment: Clinical profiles and long-term outcome (P6.124)","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"60375","DOI":"10.3390\/brainsci10060375","article-title":"Psychiatric manifestation of anti-LGI1 encephalitis","volume":"10","author":"Endres","year":"2020","journal-title":"Brain Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neurol.2017.11.004","article-title":"Autoimmune encephalitis and psychiatric disorders","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: A frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology."},{"key":"B8","author":"Nakaoku","year":"","journal-title":"A Case of Smoldering Anti-leucine Rich Glioma Inactivated 1 (LGI1) Antibody-associated Limbic Encephalitis With Faciobrachial Dystonic Seizure"},{"key":"B9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.38.6.900","article-title":"Screening for dementia by memory testing","volume":"38","author":"Grober","year":"1988","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1\u2013associated cognitive impairment: Presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/brain\/awv266","article-title":"Manic episodes are related to changes in frontal cortex: A longitudinal neuroimaging study of bipolar disorder 1","volume":"138","author":"Ab\u00e9","year":"2015","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2006.02.016","article-title":"A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder","volume":"93","author":"Robinson","year":"2006","journal-title":"J Affect Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ana.21430","article-title":"Rapidly progressive dementia","volume":"64","author":"Geschwind","year":"2008","journal-title":"Ann Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1039856218771513","article-title":"LGI1 antibody encephalitis and psychosis","volume":"26","author":"Wang","year":"2018","journal-title":"Australas Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/0004867417742522","article-title":"Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation","volume":"52","author":"Tu","year":"2018","journal-title":"Aust N Z J Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time","volume":"15","author":"van Sonderen","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neurol.2012.05.014","article-title":"Enc\u00e9phalites dysimmunitaires, donn\u00e9es cliniques, radiologiques et immunologiques","volume":"169","author":"Aupy","year":"2013","journal-title":"Rev Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0404.2005.00406.x","article-title":"FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: Correlation with clinical course and neuropsychology","volume":"111","author":"Fauser","year":"2005","journal-title":"Acta Neurol Scand."},{"key":"B20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol."},{"key":"B21","author":"Kamaleshwaran","year":"","journal-title":"18F-FDG PET\/CT Findings in Voltage-Gated Potassium Channel Limbic Encephalitis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1168302\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T06:59:41Z","timestamp":1702450781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1168302\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":22,"alternative-id":["10.3389\/fpsyt.2023.1168302"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1168302","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"article-number":"1168302"}}